Altoida

Digital biomarker-based individualized prognosis for people at risk of dementia

August 19, 2020Neelem Sheikh

At Altoida, we use digital biomarkers to radically change the method of assessing brain health and cognitive diseases. After nearly two decades of research, we are developing a platform and device to measure and analyze cognitive biomarkers associated with cognitive impairment to evaluate perceptual and memory function.
Contact Us